EEPD1 attenuates radiation-induced cardiac hypertrophy and apoptosis by degrading FOXO3A in cardiomyocytes: Effect of
Radiation-induced heart disease (RIHD) is a severe delayed complication of thoracic irradiation (IR). Endonuclease/exonuclease/phosphatase family domain-containing 1 ( EEPD1 ) plays an important role in DNA damage repair, but its role in RIHD is less known. In this study, EEPD1 global knockout mice,...
Gespeichert in:
Veröffentlicht in: | Acta biochimica et biophysica Sinica 2024-08, Vol.56 (12), p.1733-1747 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Radiation-induced heart disease (RIHD) is a severe delayed complication of thoracic irradiation (IR). Endonuclease/exonuclease/phosphatase family domain-containing 1 (
EEPD1
) plays an important role in DNA damage repair, but its role in RIHD is less known. In this study,
EEPD1
global knockout mice, C57BL/6J mice, and C57BL/6J mice overexpressing
EEPD1
are treated with radiation at a total dose of 20 Gy or 0 Gy. After 9 weeks, echocardiography is used to assess cardiac hypertrophy and apoptosis. The results show that
EEPD1
deletion exacerbates radiation-induced cardiac hypertrophy and apoptosis, while
EEPD1
overexpression has the opposite effect. Further mechanistic investigations reveal that
EEPD1
interacts with
FOXO3A
and destabilizes it by catalyzing its deubiquitination. Inhibition of
FOXO3A
ameliorates cardiac hypertrophy and apoptosis after
EEPD1
knockdown. Thus,
EEPD1
protects against radiation-induced cardiac hypertrophy and apoptosis via destabilization of
FOXO3A
, which may offer new insight into therapeutic strategies for RIHD. |
---|---|
ISSN: | 1672-9145 1745-7270 |
DOI: | 10.3724/abbs.2024130 |